Table 2.
Multivariate cox regression analyses for overall survival and disease free survival in ccRCC patients
| Variables | Overall survival | Disease free survival | ||||
|---|---|---|---|---|---|---|
| HR | 95 % CI | p* | HR | 95 % CI | p* | |
| TNM stage | <0.001 | 0.003 | ||||
| III + IV vs I+II | 2.76 | 1.75–4.34 | 2.13 | 1.30–3.51 | ||
| Fuhrman | 0.044 | 0.020 | ||||
| 3 + 4 vs 1+2 | 1.85 | 1.02–3.37 | 2.19 | 1.13–4.23 | ||
| Necrosis | 0.045 | 0.015 | ||||
| Present vs Absent | 1.81 | 1.01–3.25 | 2.16 | 1.16–4.00 | ||
| ECOG PS | 0.047 | 0.267 | ||||
| ≥1 vs 0 | 1.61 | 1.01–2.56 | 1.35 | 0.80–2.29 | ||
| ST3GAL-1 | 0.006 | 0.001 | ||||
| High vs Low | 1.88 | 1.20–2.94 | 2.30 | 1.40–3.77 | ||
Abbreviations: ECOG PS Eastern Cooperative Oncology Group performance status, CI confidence interval, HR hazard ratio
*Data obtained from the Cox proportional hazards model; p <0.05 was regard as statistically significant